Literature DB >> 20109580

Effects and applications of ultrashort-lived prehydrated electrons in radiation biology and radiotherapy of cancer.

Qing-Bin Lu1.   

Abstract

The subpicosecond-lived prehydrated electron (e(pre)(-)) is a fascinating species in radiation biology and radiotherapy of cancer. Using femtosecond time-resolved laser spectroscopy, we have recently resolved that e(pre)(-) states are electronically excited states and have lifetimes of approximately 180 fs and approximately 550 fs, after the identification and removal of a coherence spike, respectively. Notably, the weakly bound e(pre)(-) (< 0 eV) has the highest yield among all the radicals generated in the cell during ionizing radiation. Recently, it has been demonstrated that dissociative electron transfer (DET) reactions of e(pre)(-) can lead to important biological effects. By direct observation of the transition states of the DET reactions, we have showed that DET reactions of e(pre)(-) play key roles in bond breakage of nucleotides and in activations of halopyrimidines as potential hypoxic radiosensitizers and of the chemotherapeutic drug cisplatin in combination with radiotherapy. This review discusses all of these findings, which may lead to improved strategies in radiotherapy of cancer, radioprotection of humans and in discovery of new anticancer drugs. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20109580     DOI: 10.1016/j.mrrev.2010.01.012

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  9 in total

1.  Hydrated electrons react with high specificity with cisplatin bound to single-stranded DNA.

Authors:  B Behmand; P Cloutier; S Girouard; J R Wagner; L Sanche; D J Hunting
Journal:  J Phys Chem B       Date:  2013-12-10       Impact factor: 2.991

2.  Direct observation of ultrafast-electron-transfer reactions unravels high effectiveness of reductive DNA damage.

Authors:  Jenny Nguyen; Yuhan Ma; Ting Luo; Robert G Bristow; David A Jaffray; Qing-Bin Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-05       Impact factor: 11.205

3.  Electron transfer-based combination therapy of cisplatin with tetramethyl-p-phenylenediamine for ovarian, cervical, and lung cancers.

Authors:  Ting Luo; Jianqing Yu; Jenny Nguyen; Chun-Rong Wang; Robert G Bristow; David A Jaffray; Xiao Zhen Zhou; Kun Ping Lu; Qing-Bin Lu
Journal:  Proc Natl Acad Sci U S A       Date:  2012-06-08       Impact factor: 11.205

4.  In Vitro and In Vivo Studies of Non-Platinum-Based Halogenated Compounds as Potent Antitumor Agents for Natural Targeted Chemotherapy of Cancers.

Authors:  Qing-Bin Lu; Qin-Rong Zhang; Ning Ou; Chun-Rong Wang; Jenny Warrington
Journal:  EBioMedicine       Date:  2015-04-20       Impact factor: 8.143

5.  Antioxidant induces DNA damage, cell death and mutagenicity in human lung and skin normal cells.

Authors:  Linda Y Lu; Ning Ou; Qing-Bin Lu
Journal:  Sci Rep       Date:  2013-11-08       Impact factor: 4.379

6.  Preclinical Evaluation of 1,2-Diamino-4,5-Dibromobenzene in Genetically Engineered Mouse Models of Pancreatic Cancer.

Authors:  Robert G Goetze; Soeren M Buchholz; Ning Ou; Qinrong Zhang; Shilpa Patil; Markus Schirmer; Shiv K Singh; Volker Ellenrieder; Elisabeth Hessmann; Qing-Bin Lu; Albrecht Neesse
Journal:  Cells       Date:  2019-06-09       Impact factor: 6.600

7.  New combination chemotherapy of cisplatin with an electron-donating compound for treatment of multiple cancers.

Authors:  Qinrong Zhang; Qing-Bin Lu
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

Review 8.  Reaction Cycles of Halogen Species in the Immune Defense: Implications for Human Health and Diseases and the Pathology and Treatment of COVID-19.

Authors:  Qing-Bin Lu
Journal:  Cells       Date:  2020-06-13       Impact factor: 6.600

9.  5-Nitro-2,4-Dichloropyrimidine as an Universal Model for Low-Energy Electron Processes Relevant for Radiosensitization.

Authors:  Thomas F M Luxford; Stanislav A Pshenichnyuk; Nail L Asfandiarov; Tomáš Perečko; Martin Falk; Jaroslav Kočišek
Journal:  Int J Mol Sci       Date:  2020-10-31       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.